In Washington, mesothelioma treatment and doctors can be found in the Seattle area. Some of the best cancer care in the world is right here in the state, including research, clinical trials, and comprehensive cancer centers. At these facilities, mesothelioma patients will find specialists and innovative treatments.
Washington Cancer Centers
If you have been diagnosed with mesothelioma and live in Washington, you have excellent options for treatment. Two cancer centers in the Seattle area serve large populations and draw patients from all over the state, including those with a mesothelioma diagnosis.
Swedish Cancer Institute
The Swedish Cancer Institute in Seattle serves a diverse population, including patients with mesothelioma. In addition to an entire staff of experienced cancer physicians, Swedish also has a world-renowned mesothelioma specialist and surgeon.[1]
- The Swedish staff works in collaborative teams to create personalized treatment plans for each patient.
- Patients with pleural mesothelioma come from all over to get expert care at Swedish.
- Treatment for pleural mesothelioma here includes chemotherapy, surgery, radiation therapy, the innovative SMART protocol for radiation, and an antiangiogenesis drug, developed at Swedish.
- Peritoneal mesothelioma patients can receive HIPEC at Swedish, one of the most effective treatments for this type of cancer but one that is not widely available.
- Swedish conducts hundreds of clinical trials, which lead to new treatments and give patients with challenging cancers more options.
- In addition to cancer treatments, Swedish offers a range of supportive services, including counseling, complementary therapies, genetic counseling, cancer rehabilitation, nutrition consultations, and palliative care.
Fred Hutchinson/University of Washington Cancer Consortium
The Fred Hutchinson/University of Washington Cancer Consortium, based in Seattle, is a group of four institutions. One is focused on cancer research, while the other three provide patient care. These include Seattle Children’s Hospital, The University of Washington, and the Seattle Cancer Care Alliance.
Collectively, this group is recognized by the National Cancer Institute as a Comprehensive Cancer Center and is an excellent choice for treatment for mesothelioma patients.[2]
- The Consortium staff includes experts in all areas of cancer care, including those most important for managing mesothelioma: chemotherapy, radiation therapy, and surgery.
- Other treatments available at these facilities include gamma knife radiosurgery, hormone therapy, immunotherapy, bone marrow transplants, precision medicine, proton beam therapy, and targeted therapies.
- Experienced physicians at both treatment facilities can treat pleural mesothelioma.
- The research branch of the consortium offers patients access to new treatments through clinical trials.
Mesothelioma Specialists in Washington
A mesothelioma diagnosis can be frightening, but you will be in good hands with the experts and specialists in Washington.
Eric Vallieres, M.D.
Dr. Vallieres is a thoracic surgeon and the director of the Swedish Lung Cancer Program. His area of treatment expertise includes pleural mesothelioma.[3]
Dr. Vallieres is one of the few surgeons in the U.S. skilled and experienced enough to perform an extrapleural pneumonectomy, a radical, sometimes curative surgery for mesothelioma. He has also been instrumental in developing and advocating for multimodal treatment for mesothelioma patients.[3]
Evan S. Ong, M.D.
A surgical oncologist at Swedish Cancer Institute, Dr. Ong specializes in the surgical treatment of gastrointestinal cancers. This includes helping patients with peritoneal mesothelioma. He provides patients with cytoreductive surgery followed by HIPEC.[4]
Farhood Farjah, M.D.
Dr. Farjah is a thoracic surgeon at the University of Washington. He trained at Memorial Sloan-Kettering Cancer Center, a leader in mesothelioma treatment. Dr. Farjah specializes in minimally invasive surgery, lung cancer, and pleural mesothelioma.[5]
Additional Mesothelioma Specialists in Washington
- Christina Baik, M.D., medical oncologist, Fred Hutchinson Cancer Center, Seattle
- Keith D. Eaton, M.D., medical oncologist, Fred Hutchinson Cancer Center, Seattle
- Alexander S. Farivar, M.D., thoracic surgeon, Swedish Medical Center, Seattle
- Harveshp Mogal, M.D., surgical oncologist, Fred Hutchinson Cancer Center, Seattle
- Michael S. Mulligan, M.D., cardiothoracic surgeon, University of Washington Medicine, Seattle
- Ramesh Rengan, M.D., radiation oncologist, Fred Hutchinson Cancer Center, Seattle
- Rafael Santana-Davila, M.D., medical oncologist, Fred Hutchinson Cancer Center, Seattle
- Diane Tseng, M.D., medical oncologist, Fred Hutchinson Cancer Center, Seattle
Washington Clinical Trials for Mesothelioma Patients
If you have an aggressive and difficult-to-treat cancer like mesothelioma, consider joining a clinical trial. These are studies of new treatments and therapies that require patients to participate. The new medicines are mostly regarded as safe, but there are still risks. Talk to your medical team about your options for qualifying for clinical trials.
A few clinical trials going on in Washington need mesothelioma patients to apply and participate:
- Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma. This is a phase II study of the safety and effectivness of immunotherapy used to treat mesothelioma before patients undergo surgery. Patients with sarcomatoid mesothelioma in stages 1 through 3 may quality.[6]
- A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors. This study is for patients with advanced solid tumors that are difficult to treat or that have spread throughout the body. The stdy is investigating a new drug for safety and effectiveness.[7]
- A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas. Mesothelioma patients may qualify for this study of a new drug that targets a specific molecule overexpressed in many cancers.[8]
A diagnosis of mesothelioma requires expert treatment and guidance. If you have this cancer and live in Washington, know that there are options. You have two world-class facilities for cancer care and many specialists to provide cutting-edge treatment.
Mary Ellen Ellis
WriterMary Ellen Ellis has been the head writer for Mesothelioma.net since 2016. With hundreds of mesothelioma and asbestos articles to her credit, she is one of the most experienced writers on these topics. Her degrees and background in science and education help her explain complicated medical topics for a wider audience. Mary Ellen takes pride in providing her readers with the critical information they need following a diagnosis of an asbestos-related illness.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- Swedish. (n.d.). Swedish Cancer Institute.
Retrieved from: https://www.swedish.org/services/cancer-institute - Fred Hutch/University of Washington Cancer Consortium. (n.d.). About the Cancer Consortium.
Retrieved from: https://www.cancerconsortium.org/about.html - Swedish. (n.d). Eric Vallieres, M.D., FRCSC.
Retrieved from: https://www.swedish.org/doctors/thoracic-surgical-oncology/wa/seattle/eric-vallieres-1881750743 - Swedish. (n.d.). Evan S. Ong, FACS, MD, MS.
Retrieved from: https://www.swedish.org/doctors/surgical-oncology/wa/seattle/evan-ong-1073541959 - UW Medicine. (n.d.). Farhood Farjah, MD, MPH, FACS.
Retrieved from: https://www.uwmedicine.org/bios/farhood-farjah#about-tab - National Institutes of Health. (2024, May 23). Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma.
Retrieved from: https://clinicaltrials.gov/study/NCT05647265 - National Institutes of Health. (2024, July 26). A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors.
Retrieved from: https://clinicaltrials.gov/study/NCT05571839 - National Institutes of Health. (2024, August 2). A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas.
Retrieved from: https://clinicaltrials.gov/study/NCT04104776